[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes].
Z Geburtshilfe Neonatol
2019
223
6
373-394
[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth].
Z Geburtshilfe Neonatol
2019
223
5
304-316
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
Gynecol Oncol
2019
154
1
65-71
Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice.
Geburtsh Frauenheilk
2019
79
3
268-280
Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer.
Geburtsh Frauenheilk
2019
79
3
256-267
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors.
Breast Care (Basel)
2019
14
2
86-92
EMBRACA: Efficacy and safety of talazoparib or physician's choice of therapy in patients with advanced breast cancer and a germline BRCA1/2 mutation: A regional analysis
Cancer Res
2019
79 Suppl S
4
REASSURE-Effects of Reiki as supportive treatment during chemotherapy of breast cancer: A prospective, randomized, controlled clinical trial
Cancer Res
2019
79 Suppl S
4
RESCUE: Reaching for Evidence-baSed Chemotherapy Use in Endocrine sensitive breast cancer - A prospective health care study on risk assessment by the clinicomolecular test EndoPredict (R) and long-term patient outcome in early luminal breast cancer
Cancer Res
2019
79 Suppl S
4
Feasibility of quantitative sensory testing (QST) in clinical routine as a tool to evaluate chemotherapy-induced peripheral neuropathy (CIPN) amongst breast cancer patients treated with taxanes
Ann Oncol
2019
30 Suppl 3